SR 2020
Commitment
Description
4. Building resilience at home and overseas
Situation Centre
and Cabinet Office
Briefing Rooms (CO)
• £9.3m to provide continued support to the COBR crisis
suite and establish a Situation Centre which will provide live
data, analysis and insights to decision-makers on what is
happening in the UK and around the world, strengthening
our ability to identify, understand and respond to national
security issues and crises.
Climate change and
biodiversity
• £12bn investment to support a green industrial revolution
including innovative clean energy technologies, low
hydrogen carbon production, carbon capture and storage,
offshore wind and nuclear power. Provides funding for
the Prime Minister’s ten-point plan, which has set out
the Government’s vision to tackle climate change while
simultaneously supporting hundreds of thousands of
jobs across the UK.
• The Prime Minister committed in 2019 to double the UK’s
public ICF to at least £11.6bn between 2021 and 2025.
ICF will help developing countries limit their greenhouse gas
emissions and adapt to the impacts of climate change.
• £5.2bn in the next six-year flood and coastal defence
programme, and £200m on innovative resilience measures
over the same period. This is to better protect homes and
communities across England from flooding and to ensure
they are better prepared for when it does happen.
• This accompanies allocations for the Nature for Climate
Fund (£92m), Green Recovery Challenge Fund (£80m)
and an additional £7m for biodiversity conservation in the
Overseas Territories.
Health resilience
(DHSC, BEIS,
MHCLG, FCDO)
• £6bn to develop and procure COVID-19 vaccines, as
well as over £5.4bn to help local authorities respond to
COVID-19 in 2020-21.
• £1.3bn to DHSC for R&D to continue the world-leading
work of the National Institute for Health Research and
Genomics England and their research into better patient
outcomes, including on COVID-19 research, as well as
supporting the wider UK life sciences sector.
• £548m available through the COVAX Advance Market
Commitment to support developing countries’ access to
COVID-19 vaccines.
104
Integrated Review
Select target paragraph3
Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents